Results 1 to 10 of about 3,685 (164)

Efgartigimod Combined With Steroid Treatment for HAM/TSP: A Case Report [PDF]

Annals of Clinical and Translational Neurology
HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive neurological disorder with limited treatment options. We report a 54‐year‐old female with decade‐long, progressive HAM/TSP, previously refractory to rituximab, who ...
Jiahui Zeng, Wotu Tian, Jingran Yang, Yanping Yang, Li Cao, Xinghua Luan   +5 more
doaj   +3 more sources

Tropical spastic paraparesis – anesthetic approach

Brazilian Journal of Anesthesiology, 2017
Introduction: HTLV-1 infection is endemic in Japan, Caribbean, Africa, and South America. It is transmitted from mother to child, sexual contact, blood transfusions, or sharing needles.
Margarida Rodrigues, Francisco Cabral, Fátima Pina   +2 more
doaj   +7 more sources

Tropical spastic paraparesis in Northeastern Brazil [PDF]

Arquivos de Neuro-Psiquiatria, 1989
Ten possible cases of tropical spastic paraparesis (TSP) in Northeastern Brazil (Ceará) are presented. They show the typical symptoms and signs of TSP consisting of weakness of the lower limbs, spastic gait, hiperreflexia, bladder dysfunction and ...
C. M. de Castro Costa, M. R. Salgueiro, H. Carton, O. C. do Vale, A. M. de Arruda   +4 more
doaj   +4 more sources

Brazilian studies on tropical spastic paraparesis: a meta-analysis [PDF]

Arquivos de Neuro-Psiquiatria, 1994
Tropical spastic paraparesis (TSP) is a chronic progressive myelopathy and in most of the cases has a retroviral (HTLV-1) etiology, when it is denominated HTLV-1 associated-mielopathy (HAM/TSP).
C.M. de Castro Costa, H. Carton, P. Goubau, J.A.C. D'Almeida   +3 more
doaj   +4 more sources

Lived Experience of Human T-cell Leukemia Virus type-1 -Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Phenomenology Study [PDF]

Iranian Journal of Medical Sciences
Background: Human T-cell Leukemia Virus type-1 (HTLV-1) -associated myelopathy causes sufferers to experience changes in several aspects of their lives.
Malihe Davoudi, Reza Boostani, Zahra Sadat Manzari   +2 more
doaj   +2 more sources

Urodynamic findings and vibegron effects on neurogenic lower urinary tract dysfunction caused by human T‐cell leukemia virus type I‐associated myelopathy/tropical spastic paraparesis [PDF]

IJU Case Reports
Introduction Human T‐cell lymphotropic virus type 1 infection can cause HTLV‐1‐associated myelopathy/tropical spastic paraparesis, characterized by spastic paralysis of both lower limbs. More than 90% of HAM/TSP patients show lower urinary tract symptoms
Tomoyuki Kumekawa, Hidenori Akaihata, Hiroki Natsuya, Yuki Harigane, Hitomi Imai, Kanako Matsuoka, Ryo Tanji, Junya Hata, Soichiro Ogawa, Yoshiyuki Kojima   +9 more
doaj   +2 more sources

The Barriers of Coping with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Content Analysis Study [PDF]

Journal of Evidence-Based Care, 2023
Background: HTLV-1-associated myelopathy is associated with constant stress, so it is very important to cope with this disease. To improve the coping of patients with this disease, it is necessary to deeply identify its barriers.Aim: The present study ...
Malihe Davoudi, Reza Boostani, Zahra Sadat Manzari   +2 more
doaj   +1 more source

Magnetic resonance imaging for Human T-cell lymphotropic virus type 1 (HTLV1-) associated myelopathy/tropical spastic paraparesis patients: a systematic review [PDF]

Reviews in Clinical Medicine, 2015
Introduction: Human T-cell lymphotropic virus type 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis is a chronic progressive neurologic disease which might be associated by brain and spinal cord atrophy and lesions.
Fariba Zemorshidi, Reza Boostani, Mohammad Mehdi Etemadi   +2 more
doaj   +3 more sources

Intravesical injection of onabotulinumtoxinA in neurogenic overactive bladder patients with human T‐cell leukemia virus type 1‐associated myelopathy: A single‐institution case series

IJU Case Reports, 2021
Introduction Neurogenic overactive bladder is a main feature of human T‐cell leukemia virus type 1‐associated myelopathy/tropical spastic paraparesis. We successfully performed intravesical onabotulinumtoxinA therapy for refractory neurogenic overactive ...
Tomohiro Matsuo, Tatsufumi Nakamura, Katsuya Sato, Yasuyoshi Miyata, Hideki Sakai   +4 more
doaj   +1 more source

Physiotherapy Methods Applied in the Prevention of Functional Loss Associated with Human T-Lymphotropic Virus 1 Infection: An Overview

Infectious Disease Reports, 2023
To achieve the objective of this study, we conducted a narrative review on physical therapeutic modalities applied to prevent functional losses associated with human T-lymphotropic virus 1 (HTLV-1) infections to promote health education and viable and ...
Izabela Mendonça de Assis, Bianca Callegari, Maisa Silva de Sousa   +2 more
doaj   +1 more source